Report #2873189

Received Nov 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (2)

FatigueInjection site reaction

Symptom narrative

injection site reaction; Fatigue; This non-serious case was reported by a consumer via sales rep and described the occurrence of injection site reaction in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site reaction (Verbatim: injection site reaction) and fatigue (Verbatim: Fatigue). The outcome of the injection site reaction and fatigue were resolved. The reporter considered the injection site reaction and fatigue to be related to Shingrix. The company considered the injection site reaction and fatigue to be related to Shingrix. Additional Information: GSK Receipt Date: 13-NOV-2025 The batch number was not provided, and we are unable to contact the reporter.